ArticlePloS one2016

Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.

David Molina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.